Dedicated To Delivering Accountability, Maximizing Compensation And Facilitating Your Recovery

Uncategorized

Pfizer Halts Distribution of Anti-smoking Drug After Finding Carcinogen

Overview Drug manufacturer Pfizer announced that it is pausing distribution of its anti-smoking medication, Chantix, after elevated levels of cancer-causing agents called nitrosamines were found in the pills. At this time, Pfizer has not announced which nitrosamines were found in Chantix or how they got into the pills.   Chantix is a prescribed medication that aids with quitting smoking. Pfizer…

Study Finds Diagnostic Mistakes a Big Contributor to Malpractice Suits

Diagnostic errors are more than just a danger to patients or an ethical issue, they can also present a liability issue for physicians. Dana Siegal, RN, discussed this data as well as ways for the healthcare industry to evolve at the 2021 Working Together to Improve Diagnosis virtual conference hosted by the Iowa Healthcare Collaborative. Data and Diagnostic Error Cases…

Philips Recalls Ventilators, Sleep Apnea Machines Due to Health Risks

Overview of Recall The recall includes millions of units of the Philips Bi-level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAP), and mechanical ventilator devices. Most of these recalled devices are DreamStation products. Philips stated that the defect in the products was related to the polyester-based polyurethane (PE-PUR) sound abatement foam in the devices. When cleaned incorrectly or…

Xeljanz May Pose Risk of Heart Problems and Even Cancer, Recent Study Shows

On February 4th, the Food and Drug Administration announced that preliminary results from a clinical trial of arthritis drug Xeljanz pointed to an increased risk of developing cancer or serious heart problems. Below, the pharmaceutical liability attorneys at Peter Angelos Law provide a brief overview of the FDA’s new findings and recommendations for patients who may have been affected by…

FDA Issues a Class I Recall of the ROSA Brain 3.0 Robotic Surgery System by Zimmer Biomet

Medical device company Zimmer Biomet recently issued a Class I recall of the ROSA Brain 3.0 Robotic Surgery System due to a major software issue that caused the device to malfunction. The malfunction could cause serious injury or even death to patients receiving neurosurgery that utilizes the device. Here, the medical product liability attorneys at Peter Angelos Law detail the…

FDA Gives Ambien and Other Prescription Sleep Drugs a Black Box Warning

In April 2019, the FDA placed a Black Box Warning, the highest possible warning the FDA can mandate, on the updated labels of prescription sleep drugs, including Ambien and Lunesta. These new warnings will alert patients of risks including sleep driving, drowning and suicide attempts. Here, the Baltimore pharmaceutical liability attorneys at The Law Offices of Peter Angelos detail the…

Asbestos and Mesothelioma: What Veterans Should Know

When members of the armed forces return home after serving our country, they are often at risk for suffering severe mental conditions including post-traumatic stress disorder and depression. What many individuals may not be aware of, however, is the risk of developing mesothelioma due to asbestos exposure during deployment. Here, the mesothelioma attorneys at The Law Offices of Peter Angelos…

Continuation of Clinical Trial Results Concerning Invokana Amputation Risks

Invokana is a popular diabetes drug that is commonly administered to lower blood sugar in diabetes patients. However, clinical trials point to the conclusion that Invokana may increase the risk of amputations in diabetics. Here, the pharmaceutical liability attorneys at The Law Offices of Peter Angelos provide updates on the clinical trial results concerning Invokana amputation risks. Diabetes Patients Have…